Tumor sialylation regulates G-CSF stability and promotes neutrophil-mediated immunosuppression in breast cancer

Journal:

Nature Communications

Published:

2026-05-22

DOI:

10.1038/s41467-026-73401-9

Affiliations:

21

Authors:

26

Go to article

Institutions	Authors	Share
Institute of Molecular Biotechnology (IMBA), Austria	6.916667	0.27
Kantonsspital St. Gallen, Switzerland	3.250000	0.13
Hannover Medical School (MHH), Germany	3.000000	0.12
Institute Gustave-Roussy (IGR), France	2.583333	0.10
University of Natural Resources and Life Sciences, Vienna (BOKU), Austria	2.000000	0.08
Research Institute of Molecular Pathology (IMP), Austria	2.000000	0.08
Medical University of Vienna (MUW), Austria	1.916667	0.07
The University of British Columbia (UBC), Canada	1.250000	0.05
Vienna BioCenter PhD Program, Austria	0.666667	0.03
University Hospital Zurich (UHZ), Switzerland	0.500000	0.02
Cordelier Research Center (CRC), France	0.333333	0.01
SIRIC CARPEM, France	0.333333	0.01
University Hospital Tübingen (UKT), Uni Tübingen, Germany	0.250000	0.01
University of Paris-Saclay, France	0.250000	0.01
Tumour Immunology and Anti-Cancer Immunotherapy Unit, France	0.250000	0.01
Center of Clinical Investigations in Biotherapies of Cancer (CICBT), France	0.250000	0.01
Helmholtz Centre for Infection Research (HZI), Germany	0.250000	0.01

Interested in Oncology and Carcinogenesis?